Gene signatures can help in predicting the likely course of the disease, including its potential for recurrence and metastasis. Prognostic gene signatures give clinicians vital information that can influence decisions on the intensity and type of treatment. For instance, the MammaPrint test uses a 70-gene signature to assess the risk of breast cancer recurrence, assisting in the decision-making process regarding adjuvant chemotherapy.
